{"entity":{"id":"hospital-roosevelt-guatemala","kind":"institution","name":"Hospital Roosevelt","aka":["Roosevelt Hospital, Guatemala City"],"tldr":"A public referral hospital in Guatemala City that treats people sent from departmental and regional hospitals across the country free of charge.","summary":"Hospital Roosevelt's own history says construction began in 1944, with support from the United States government, and finished in 1955, and that a radioisotope laboratory opened in 1962 with a cobalt-60 unit among the donated equipment. It describes itself as receiving patients from the capital and referred from departmental and regional hospitals across the country, providing specialised medical and hospital services free of charge in internal medicine, surgery, gynaecology, paediatrics, ophthalmology and other subspecialties. ClinicalTrials.gov lists Hospital Roosevelt as a Guatemala City site of the HERA trial of trastuzumab after surgery for HER2-positive breast cancer. Coordinates are Nominatim's.","asOf":"2026-11-11","links":[{"label":"Hospital Roosevelt: history","url":"https://hospitalroosevelt.gob.gt/historia/"},{"label":"ClinicalTrials.gov NCT00045032 (site list)","url":"https://clinicaltrials.gov/study/NCT00045032"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["incan-guatemala"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Guatemala City","country":"GT","lat":14.614,"lng":-90.542,"institutionType":"hospital","website":"https://hospitalroosevelt.gob.gt","programs":["Free public specialist care for patients referred from across Guatemala"]},"route":"/institutions/hospital-roosevelt-guatemala/","neighbours":{"institution":[{"id":"incan-guatemala","kind":"institution","name":"Instituto de Cancerología y Hospital Dr. Bernardo del Valle S. (INCAN)","route":"/institutions/incan-guatemala/"}],"trial":[{"id":"hera-b31-n9831","kind":"trial","name":"HERA, NSABP B-31 & NCCTG N9831 (adjuvant trastuzumab)","route":"/trials/hera-b31-n9831/"}]}}